The Celiac Disease Treatment Market Overview 2025 report reveals that the market size has grown significantly over the past few years, with projections indicating further expansion.
The celiac disease treatment market has seen substantial growth recently. The market size was $0.61 billion in 2024 and is projected to reach $0.67 billion in 2025, with a compound annual growth rate of 9.9%.
The Celiac Disease Treatment Global Market Report 2025 anticipates a strong upward trend for the industry. By 2029, the market size is projected to reach $0.96 billion, growing at a compound annual growth rate (CAGR) of 9.6%.
Download Your Free Sample of the 2025 Celiac Disease Treatment Market Report and Uncover Key Trends Now!The key drivers in the celiac disease treatment market are:
• Rise in global prevalence of celiac disease and increasing diagnosis rates
• Ongoing clinical trials for new treatments and growing demand for gluten-free alternatives
• Supportive regulatory initiatives for rare diseases and increased healthcare spending
• Adoption of novel non-dietary therapies and advancements in enzyme supplements, personalized medicine, and clinical trials.
The celiac disease treatment market covered in this report is segmented –
1) By Treatment Type: Vitamins And Minerals, Gluten Degrading Enzymes, Symptomatic Treatment, Other Treatments
2) By Enzyme Type: Distension, Diarrhoea, Anorexia, Bloating, Gas, Fatigue
3) By Diagnosis: Serological Tests, Genetic Testing, Biopsy
4) By Distribution Channel: Hospitals, Research Centres, Clinics, Other Distribution Channels
The key trends in the celiac disease treatment market are:
• Adoption of novel non-dietary therapies is an emerging trend.
• Advancements in enzyme supplements are shaping the future of the market.
• A trend towards personalized medicine approaches is gaining momentum.
• Development of peptide-based immunotherapies and improved diagnostic tools are also emerging trends.
Major players in the celiac disease treatment market are:
• Pfizer Inc.
• Johnson And Johnson
• F. Hoffmann-La Roche Ltd.
• Merck And Co. Inc.
• Sanofi S.A.
• Novartis AG
• Takeda Pharmaceuticals Company Ltd.
• Amgen Inc.
• General Mills Inc.
• Viatris Inc.
• Teva Pharmaceutical Inc.
• Nestlé Health Science
• Hikma Pharmaceuticals PLC
• Amneal Pharmaceuticals LLC
• Zydus Pharmaceuticals Inc.
• Glenmark Pharmaceuticals Company Ltd.
• West-Ward Pharmaceuticals Company Ltd
• Innovate Biopharmaceutical
• Acto Biosciences
• ImmunogenX
North America was the largest region in the celiac disease treatment market in 2024